No Data
Even Though Amneal Pharmaceuticals (NASDAQ:AMRX) Has Lost US$78m Market Cap in Last 7 Days, Shareholders Are Still up 125% Over 5 Years
Is Amneal Pharmaceuticals, Inc. (AMRX) the Best Pharma Stock to Buy for Long Term Growth?
Amneal Donates $1.5 Million to Support Patients During Parkinson's Awareness Month
AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."
① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.
Amneal Pharmaceuticals Down Nearly 9%, on Pace for Largest Percent Decrease Since October 2023 -- Data Talk
Improved Revenues Required Before Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Shares Find Their Feet
